BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang F, Xu C, Ning L, Hu F, Shan G, Chen H, Yang M, Chen W, Yu J, Xu G. Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis. PLoS One 2016;11:e0167109. [PMID: 27997555 DOI: 10.1371/journal.pone.0167109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhang F, Xu C, Ning L, Hu F, Shan G, Chen H, Yang M, Chen W, Yu J, Xu G. Correction: Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis. PLoS One 2019;14:e0212300. [PMID: 30730981 DOI: 10.1371/journal.pone.0212300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Ning L, Shan G, Sun Z, Lou X, Zhang F, Li S, Du H, Yu J, Chen H, Xu G. Serum proteome profiles to differentiate Crohn disease from intestinal tuberculosis and primary intestinal lymphoma: A pilot study. Medicine (Baltimore) 2019;98:e18304. [PMID: 31852111 DOI: 10.1097/MD.0000000000018304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Di Narzo AF, Brodmerkel C, Telesco SE, Argmann C, Peters LA, Li K, Kidd B, Dudley J, Cho J, Schadt EE, Kasarskis A, Dobrin R, Hao K. High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease. J Crohns Colitis 2019;13:462-71. [PMID: 30445421 DOI: 10.1093/ecco-jcc/jjy190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Chen Y, Wang JC, Yang CM, Fan Q, Zheng J, Liu H. Positive acceleration adaptive training attenuates gastric ischemia-reperfusion injury through COX-2 and PGE2 expression. Exp Ther Med 2019;17:2901-6. [PMID: 30930978 DOI: 10.3892/etm.2019.7288] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Roy S, Ghosh S, Banerjee M, Laha S, Bhattacharjee D, Sarkar R, Ray S, Banerjee A, Ghosh R, Halder A, Ghosh A, Chatterjee R, Datta S, Dhali GK, Banerjee S. A combination of circulating microRNA-375-3p and chemokines CCL11, CXCL12, and G-CSF differentiate Crohn's disease and intestinal tuberculosis. Sci Rep 2021;11:23303. [PMID: 34857759 DOI: 10.1038/s41598-021-02383-z] [Reference Citation Analysis]
6 Zhu C, Yu Y, Wang S, Wang X, Gao Y, Li C, Li J, Ge Y, Wu X. A Novel Clinical Radiomics Nomogram to Identify Crohn's Disease from Intestinal Tuberculosis. J Inflamm Res 2021;14:6511-21. [PMID: 34887674 DOI: 10.2147/JIR.S344563] [Reference Citation Analysis]
7 Cui G, Fan Q, Li Z, Goll R, Florholmen J. Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. EBioMedicine 2021;66:103329. [PMID: 33862588 DOI: 10.1016/j.ebiom.2021.103329] [Reference Citation Analysis]
8 Sharma V. Differentiating intestinal tuberculosis and Crohn disease: Quo Vadis. Expert Rev Gastroenterol Hepatol 2020;14:647-50. [PMID: 32552311 DOI: 10.1080/17474124.2020.1785870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Ning L, Shan G, Sun Z, Zhang F, Xu C, Lou X, Li S, Du H, Chen H, Xu G. Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease. Biomed Res Int. 2019;2019:3950628. [PMID: 31179321 DOI: 10.1155/2019/3950628] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
10 Mehta V, Desai D, Abraham P, Rodrigues C. Making a Positive Diagnosis of Intestinal Tuberculosis with the Aid of New Biologic and Histologic Features: How Far Have We Reached? Inflamm Intest Dis 2019;3:155-60. [PMID: 31111030 DOI: 10.1159/000496482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gisbert JP, Chaparro M. Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review.J Crohns Colitis. 2019;13:374-384. [PMID: 30307487 DOI: 10.1093/ecco-jcc/jjy158] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
12 Zaki A, Ramadan RA, Moez P, Ghareeb H, Elkarmouty A. Plasma Peptidome Pattern of Breast Cancer Using Magnetic Beads-Based Plasma Fractionation and MALDI-TOF MS: A Case Control Study in Egypt. Asian Pac J Cancer Prev 2019;20:175-84. [PMID: 30678429 DOI: 10.31557/APJCP.2019.20.1.175] [Reference Citation Analysis]